Afficher la notice abrégée

Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin

dc.contributor.authorSorlozano Puerto, Antonio 
dc.contributor.authorNavarro Marí, José María
dc.contributor.authorGutiérrez Fernández, José 
dc.date.accessioned2024-04-26T09:09:13Z
dc.date.available2024-04-26T09:09:13Z
dc.date.issued2017-01
dc.identifier.citationSorlózano-Puerto A, Navarro-Marí JM, Gutiérrez-Fernández J. 2017. Activity of fosfomycin on clinical isolates of Campylobacter jejuni and Campylobacter coli of enteric origin. Antimicrob Agents Chemother 61:e02317-16. https://doi.org/10.1128/ AAC.02317-16es_ES
dc.identifier.urihttps://hdl.handle.net/10481/91181
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiologyes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleActivity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origines_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1128/AAC.02317-16
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]
Nom:
Activity_of_Fosfomycin_on_Clin ...
Taille:
184.5Ko
Format:
PDF

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional